K. Davis v. PA DOC

CourtCommonwealth Court of Pennsylvania
DecidedOctober 6, 2020
Docket40 M.D. 2020
StatusUnpublished

This text of K. Davis v. PA DOC (K. Davis v. PA DOC) is published on Counsel Stack Legal Research, covering Commonwealth Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
K. Davis v. PA DOC, (Pa. Ct. App. 2020).

Opinion

IN THE COMMONWEALTH COURT OF PENNSYLVANIA

Keith Davis, : Petitioner : : v. : No. 40 M.D. 2020 : SUBMITTED: August 21, 2020 Pennsylvania Department : of Corrections, : Respondent :

BEFORE: HONORABLE RENÉE COHN JUBELIRER, Judge HONORABLE MICHAEL H. WOJCIK, Judge HONORABLE ELLEN CEISLER, Judge

OPINION NOT REPORTED

MEMORANDUM OPINION BY JUDGE CEISLER FILED: October 6, 2020

Petitioner Keith Davis (Davis), an inmate at State Correctional Institution – Houtzdale (SCI-Houtzdale), has filed a petition for review (Petition) with our Court, in which he alleges that Respondent Pennsylvania Department of Corrections (Department) has violated his constitutional rights, due to the manner in which the Department has treated Davis’s chronic kidney disease, and seeks relief in the form of a preliminary injunction. The Department has filed preliminary objections demurring to Davis’s Petition, in which it argues that Davis has failed to articulate any viable legal claims. Upon review, we sustain the Department’s preliminary objections in part, dismiss them as moot in part, and dismiss Davis’s Petition with prejudice. I. Facts and Procedural History As recounted in Davis’s Petition and attached exhibits, Davis was evaluated by Dr. Swati Arora, a nephrologist at Allegheny General Hospital in Pittsburgh, Pennsylvania, at an unspecified point in time. Petition, ¶2, Ex. A. Dr. Arora determined that one of Davis’s kidneys had four “wrinkles” and prescribed a treatment plan that called for a biopsy of the affected kidney, as well as monthly medical tests, the results of which would be sent to Dr. Arora for her review. Id., ¶2, Ex. A. In addition, Dr. Arora recommended that Davis make two visits per year to both her and the “Transplant Division” for an “Extensive Examination.” Id., Ex. A. Dr. Muhammad Naji, the medical director at SCI-Houtzdale, subsequently determined that “[Davis’s] labs are stable . . . and opined that [labs do not] need to be drawn monthly[.]” Id. Accordingly, Dr. Naji declined to follow Dr. Arora’s recommended treatment plan for Davis’s chronic kidney disease. Id., ¶2, Ex. A. On November 25, 2019, Davis filed an inmate grievance, in which he alleged that Dr. Naji “had intentionally and knowingly [put Davis’s] life in danger from kidney failure” by refusing to facilitate Davis having biopsy appointments in either March 2019 or November 2019. Id., Ex. A. Additionally, Davis claimed that he had undergone medical tests at some point in November 2019, but that Dr. Naji had informed him that the next round of testing would not happen until January 1, 2020. Id. Davis requested that monthly labs be drawn and the results faxed to Dr. Arora to ensure that his kidney function and tacrolimus1 levels are safe, that he be transported to all prescriptive appointments, and that he be awarded $200,000 for medical neglect and punitive damages. Id. On December 23, 2019, Facility Grievance Coordinator Terri Sechrengost denied Davis’s grievance. Coordinator Sechrengost explained her decision by stating:

1 Tacrolimus is the name of an immunosuppressant drug that is used to prevent transplant recipients’ bodies from rejecting certain types of organs, including the heart and kidneys. U.S. National Library of Medicine, “Tacrolimus,” https://medlineplus.gov/druginfo/meds/a601117.html (last accessed October 5, 2020).

2 In review of Davis’[s] medical record[s,] his labs were drawn on 12/13/19 and faxed to the nephrologist. The [T]ransplant [D]ivision physician spoke with Dr. Naji and stated that they no longer need [sic] to see Davis[,] as it has been many years since he received his kidney and he is stable. Dr. Naji noted this in [Davis’s] medical record[s] and relayed this information to Davis. There is no notation in the consultation from nephrology addressing any type of biopsy that needs to be completed [on Davis’s] kidney. Id., Ex. B. Davis appealed this decision on December 27, 2019, claiming, in relevant part, “I do not believe Dr. Naji’s decision to discontinue my appointments against the orders of [Dr. Arora] was in my best interest. Dr. Naji made the decision on his own to stop all appointments to the transplant division and stopped monthly labs because my kidney’s function was ‘stable’ at one point.” Id., Ex. C. Facility Manager B. Smith denied Davis’s appeal on December 30, 2019, because Davis had failed to provide any new information that would provide [Smith] with evidence to overturn [Coordinator Sechrengost’s decision]. All points of contention were addressed and there was no indication of wrongdoing by staff. Upon reviewing all facts associated with your complaint, labs are being taken and properly sent to the [d]octor as ordered. While there are intermittent periods [during which labs] aren’t sent every thirty days, they are taken monthly and being tracked and sent accordingly for review by the Medical Department. You are also scheduled for follow up care with the physician listed, so your claims of Dr. Naji voiding those appointments is completely false. The grievance was properly investigated and [Smith] supports [Coordinator Sechrengost’s] investigation and findings. Id., Ex. D. Davis then appealed Facility Manager Smith’s denial on January 7, 2020. Id., Ex. E. Once again, Davis claimed that Dr. Naji had wrongly deviated from Dr.

3 Arora’s recommended treatment plan. Id. Additionally, Davis argued that Facility Manager Smith had not properly evaluated Davis’s appeal. He also asserted that Smith was not qualified to make such an evaluation because Smith lacked any relevant medical training and, thus, was not capable of determining whether Davis was being provided with appropriate medical care. Id. Before Davis’s most recent internal appeal was ruled upon, he filed his Petition with our Court on January 22, 2020. Therein, Davis explains that he intends to file another petition for review upon the conclusion of the grievance process, but that he requires a preliminary injunction at this point because he “is con[c]erned that the deterioration of his health is progressing with each moment and could cause [him] irrep[a]rable [harm].” Id., ¶¶1, 4. Davis alleges that the Department violated the Eighth Amendment2 by declining to follow Dr. Arora’s recommended treatment plan for his chronic kidney disease, “causing [Davis] un[n]ecessary pain[] that could lead to death.” Id., ¶¶1-2. In addition, Davis maintains that the Department violated the Fourteenth Amendment3 through a constitutionally inadequate grievance system that violated his due process rights by allowing “non-medical staff members” to rule upon the adequacy of the medical treatment provided to Davis. Id., ¶¶1, 3, 5.4 On these bases, Davis requests a preliminary injunction to compel the Department to treat his chronic kidney disease in accordance with Dr. Arora’s recommended treatment plan, as well as to prevent the Department from deviating from this plan

2 U.S. CONST. amend. VIII.

3 U.S. CONST. amend. XIV.

4 Davis also generally states, in passing, that the Department violated his rights pursuant to the Pennsylvania Constitution, but he fails to identify the specific rights secured by our Commonwealth’s Constitution that he believes have been violated.

4 or “any order prescribed by a medical professional at least until” his impending, post-grievance petition for review has been ruled upon. Id., ¶6.5 The Department responded by filing preliminary objections demurring to Davis’s Petition. Davis has responded in opposition, and this matter is now ready for our consideration. II. Standard of Review In ruling on preliminary objections, this Court accepts as true all well-pled allegations of material fact, as well as all inferences reasonably deducible from those facts. Key v. Pa. Dep’t of Corr., 185 A.3d 421 (Pa. Cmwlth. 2018).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Berman v. Lamer
874 F. Supp. 102 (E.D. Pennsylvania, 1995)
Mutual Benefit Insurance v. Haver
725 A.2d 743 (Supreme Court of Pennsylvania, 1999)
Summit Towne Centre, Inc. v. Shoe Show of Rocky Mount, Inc.
828 A.2d 995 (Supreme Court of Pennsylvania, 2003)
Hightower-Warren v. Silk
698 A.2d 52 (Supreme Court of Pennsylvania, 1997)
County of Allegheny v. Commonwealth
544 A.2d 1305 (Supreme Court of Pennsylvania, 1988)
Kretchmar v. Commonwealth, Department of Corrections
831 A.2d 793 (Commonwealth Court of Pennsylvania, 2003)
Quinby v. Plumsteadville Family Practice, Inc.
907 A.2d 1061 (Supreme Court of Pennsylvania, 2006)
Hodgson v. Bigelow
7 A.2d 338 (Supreme Court of Pennsylvania, 1939)
Key v. Pa. Dep't of Corr.
185 A.3d 421 (Commonwealth Court of Pennsylvania, 2018)
Tindell v. Department of Corrections
87 A.3d 1029 (Commonwealth Court of Pennsylvania, 2014)
Boring v. Kozakiewicz
833 F.2d 468 (Third Circuit, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
K. Davis v. PA DOC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/k-davis-v-pa-doc-pacommwct-2020.